New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free

Friday, November 13, 2026

Back to the front page

Qualcomm Custom ASICs?

Qualcomm’s Alphawave SerDes, CPU cores and HBC could support custom AI ASICs as hyperscalers build heterogeneous fleets beyond GPUs.

From X

Serenity on X

It think it's stupid that "AI Bubble" gets used over and over. In infra names you have: - 1-3x fwd P/E memory companies from Samsung to $ESMT. With HBM players now having hyperscaler multi-year price floor LTAs. - Optical companies like $POET traded -$97M under net cash. Valuing the operating business very negatively, not even at $0. - While AI companies with larger premiums continue to record demand over the next 3-5 years. Such as the new $20B LTAs signed w/ $COHR to $5B LTAs signed w/ $LITE. Can someone in the media honestly see negative EV high-beta optical companies, where 2 years of burnrate would still value the company below $0. or single digit memory companies with contracted demand + price floors years out and say that's a bubble? Many of these names are extremely profitable today... But obviously there's other elements inside the theme, such as: - Certain startups like Instinct that look like a private valuation bubble. - Leveraged Neoclouds that didn't finance properly - and AI lab valuations and commitments, which should be viewed cautiously. But everything gets grouped into one with the boogyman of "leverage" or "debt". Yes, valuations can compress or correct from macro, potential regulatory uncertainty, or potential capex reductions. But for the companies physically powering the AI buildout, it looks more like the Great AI Deleveraging of 2026... Than anything like fundamental demand destruction. As more earnings come out and free cash flow accumulates over time. I'm confident in a recovery, especially in bottlenecks, and for markets to eventually discern durability + growth over frothy valuations tied to AI.

SouthernValue on X

When I do AI supply and demand modeling, everything ex-SPCX generally fits together and makes sense and is reasonably well funded. No individual large build looks too excessive because, for the most part, large projects are pre sold before they are built, or at least before they are completed… Anthropic can fund its ambitions for the next few years pretty easily with ARR and cash on hand. Even OpenAI is sitting on a mountain of cash and can fund the majority of compute with ARR. The hyperscale clouds are allocating between internal, lab, and enterprise use cases. This changed w/ $SPCX who is trying to build ~40% of 2026 capacity next year but without a secured buyer. Just a massive bet that industry capacity plans will undershoot realized demand by a wide margin. This is the most obvious way this becomes a glut. And everything else will mostly be contracted, with spcx holding most of the bag. They also have BY FAR the most financial upside if conditions remain tight, because of their chosen path to live and die by the spot market. But I find it puzzling that markets have really not challenged them more, particularly as broadly the risk of a cyclical peak comes into focus. When parties as risk seeking as OpenAI @sama have called them speculative (one of only 2-3 potential buyers of SPCX capacity…). Also SPCX two existing customers are abundantly clear that they view their contracts as short-term / bridge capacity and intend to churn off as new cheaper capacity comes online at ~1/5 of the price.

QXO Inc Earnings Update: Q3 2026

QXO's Q3 sales rose 79% to $4.9 billion after TopBuild and Kodiak acquisitions, while acquisition debt lifted interest expense to $163…

Qure Anniversary Update

UniQure’s Huntington’s disease BLA has a May 1, 2027 priority-review date, with an FDA advisory committee expected in late first quarter.

Big Short: Fidelity & Guaranty

F&G’s main insurer held $66.5 billion of assets against $1.38 billion of statutory capital, while private credit, reinsurance dependence…

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 110

X accounts we follow

Every account on this site, hand-picked.

91 accounts

Investor letters we follow

376 firms

Sectors

Ordered by how often our editor reaches for them.